What can be done to protect the translational investigator?

The environment for investigator-initiated clinical research is changing.

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)319
Number of pages1
JournalClinical and Translational Science
Volume2
Issue number5
DOIs
StatePublished - Oct 2009
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{5282b464fc644b26aa56c055ec1d7635,
title = "What can be done to protect the translational investigator?: The environment for investigator-initiated clinical research is changing.",
author = "Karl Anderson",
year = "2009",
month = "10",
doi = "10.1111/j.1752-8062.2009.00140.x",
language = "English (US)",
volume = "2",
pages = "319",
journal = "Clinical and Translational Science",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - What can be done to protect the translational investigator?

T2 - The environment for investigator-initiated clinical research is changing.

AU - Anderson, Karl

PY - 2009/10

Y1 - 2009/10

UR - http://www.scopus.com/inward/record.url?scp=77957740637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957740637&partnerID=8YFLogxK

U2 - 10.1111/j.1752-8062.2009.00140.x

DO - 10.1111/j.1752-8062.2009.00140.x

M3 - Article

VL - 2

SP - 319

JO - Clinical and Translational Science

JF - Clinical and Translational Science

SN - 1752-8054

IS - 5

ER -